Cytotoxicity Analysis of Nineteen Medicinal Plants Extracts on Breast Adenocarcinoma (MCF-7) and Rhabdomyosarcoma (RD) Cancer Cell Lines

Message:
Article Type:
Research/Original Article (بدون رتبه معتبر)
Abstract:

The burden of cancer is alarmingly great on humans. However, the relevance of plants in combating cancer cannot be undermine. We joined the global search for anticancer agents from plants by screening nineteen (19) medicinal plant extracts on human breast carcinoma (MCF-7) and rhabdomyosarcoma (RD) cell lines using the 3- [4, 5-dimethylthiazol–2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Vincristine was used as the positive reference. Results were presented as mean IC50±standard error of the mean using GraphPad Prism (6.0). One-way ANOVA was used to establish the level of statistical significance. The results showed that twelve of the extracts were moderately cytotoxic on MCF-7 while seven were moderately active on RD (IC50, 30-100 µg/mL). Two of the extracts, Afzelia africana stem and Anogeissus leiocarpus root, showed significant activity on MCF-7 while seven had significant activity on RD (IC50.

Language:
English
Published:
Trends in Pharmaceutical Sciences, Volume:8 Issue: 1, Mar 2022
Pages:
57 to 64
magiran.com/p2438509  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!